-
Indian tech entrepreneur on mission to democratise healthcare
A leading Indian tech entrepreneur has decided to invest in a UK-based genomics data platform company to “democratise precision healthcare” and help pharmaceuticals develop targeted therapeutics.
- Categories
- Health Care
- Region
- South Asia
-
Social Business Roundup: Laureate Education Goes Big, Omidyar Gives Directly, Surdna Foundation Embraces Impact Investing
In social business news this week, the world's biggest for-profit college company raised $490 million in its public debut, Omidyar Network gave a $493,000 grant to support GiveDirectly's mission of sending unconditional cash transfers to the poor, and the Surdna Foundation announced plans to dedicate 10 percent of its endowment ($100 million) to a new impact investing fund. Read about these developments and more in our news roundup.
- Categories
- Education, Health Care, Investing, Social Enterprise
-
Global Health Leaders Seek New Ties to Tech Industry, While Aiming to Avoid ‘Innovation Addiction’
It’s easy to see global health as a far-off issue, one that doesn’t have much impact outside isolated parts of the world. But at a symposium on global health today at the University of Washington, leaders in the field argued just the opposite.
- Categories
- Health Care, Technology
-
Biocon to partner with govt for better rural health facilities
In an attempt to build a scalable healthcare model that'll make affordable healthcare accessible to rural communities, the state department of medical, health and family welfare signed a memorandum of understanding (MoU) with Biocon Foundation, the CSR arm of the pharmaceutical company headed by Kiran Mazumdar-Shaw to establish eLAJ smart clinics in 15 primary healthcare centres (PHC s) across six districts in Karnataka.
- Categories
- Health Care, Technology
- Region
- South Asia
-
India scraps funding ties with Gates Foundation on immunization
A group backed by the Bill & Melinda Gates Foundation that works on India's immunization program will now be funded by the health ministry, a government official said, a move in part prompted by fears foreign donors could influence policy making.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public policy
-
Drug Pricing Control Regime Short-Sighted
Up in arms against the central government's drug pricing control regime, the Indian pharma industry feels it is a short-sighted move that will stifle innovation in the country. Instead of slashing prices of drugs, the government must focus on holistic development of the healthcare sector, pharma honchos said here on Tuesday.
- Categories
- Health Care
- Region
- South Asia
-
This Tiny Disease-Diagnosing Microchip Only Costs A Cent To Make
Diagnosing disease often requires analysing and detecting single cells with lab tests that cost hundreds of dollars each. Hospitals in a poor country stricken with a disease epidemic like HIV or malaria simply might not have the funds to run all of those tests. Scientists are looking for a cheaper option.
- Categories
- Health Care
-
Opinion: How Pharma Can Fix Its Reputation and Its Business at the Same Time
The business model of research-based pharmaceutical companies is under significant pressure. Their return on R&D investment has dropped to its lowest levels in decades, and their public reputation in the United States and abroad is worse than ever.
- Categories
- Health Care
- Region
- North America
- Tags
- public health
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.